Cancer Drug Nilotinib Changes Alzheimer’s Disease Biomarkers -This may be a first step towards a disease-modifying treatment, phase II study suggests
Target Audience and Goal Statement: Neurologists The goal of this study was to evaluate the safety and tolerability of nilotinib, and its effect on biomarkers, in Alzheimer’s disease. Question Addressed: What […]